The National Toxicology Program (NTP) within US Dept. of Health and Human Services, an interagency program headquartered at the National Institutes of Health’s National Institute of Environmental Health Sciences (NIEHS) on Thimerosal. They report: “Poison by ingestion, subcutaneous, intravenous and possibly other routes.”

“Mercury: Medical and Public Health Issues,” a symposium that was held at the Tampa Marriott Waterside Hotel and Marina, Tampa, Florida, on April 28-30, 2004 and sponsored by the United States Department of Health and Human Services and the United States Environmental Protection Agency.

Subcommittee on Human Rights and Wellness, Committee on Government Reform of the House of Representatives, “Mercury in Medicine Report,” Washington, DC, as published in the Congressional Record, pgs. E1011-E1030, May 21, 2003.

Thomas Verstraeten, Robert Davis and Frank DeStefano, “Thimerosal VSD study, Phase I, Update, 02/29/00,” obtained by SafeMinds under FOIA in 2001. [Note: This draft ends with 5 pages, having a footer notation of “LKLK03/28/00 … Response.doc,” and starting with a page heading of “Thimerosal VSD study- Follow-up on conference call 03/02/2000,” that indicate the overall document dates to the end of March 2000.]

Thomas Verstraeten, Robert Davis, Frank DeStefano and the VSD team, “Risk of neurologic and renal impairment associated with thimerosal-containing vaccines,” obtained by SafeMinds under FOIA in 2001.

A copy of the printed Simpsonwood-meeting record (with an appended copy of the “Thimerosal VSD study, Phase I, Update, 02/29/00” document that is missing page 5, can be found on the Safe Minds website at http://www.safeminds.org/legislation/foia/simpsonwood.html.

The California OEHHA in a February 2004 document titled, “RESPONSE TO THE PETITION OF BAYER CORPORATION FOR CLARIFICATION OF THE PROPOSITION 65 LISTING OF “MERCURY AND MERCURY COMPOUNDS” AS CHEMICALS KNOWN TO CAUSE REPRODUCTIVE TOXICITY.”